Armata Pharmaceuticals, Inc. — Director's Dealing 2005

Jul 29, 2005

SEC Form 4/A — Form 4/A

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2005-07-25

Reporting Person: BIOGEN IDEC INC (10% Owner)
Reporting Person: BIOGEN IDEC MA INC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-07-25	Common Stock, $0.01 Par Value	S	8500	$0.79	Disposed	11966948	Indirect
2005-07-26	Common Stock, $0.01 Par Value	S	2500	$0.81	Disposed	11964448	Indirect
2005-07-26	Common Stock, $0.01 Par Value	S	12500	$0.82	Disposed	11951948	Indirect
2005-07-26	Common Stock, $0.01 Par Value	S	10640	$0.83	Disposed	11941308	Indirect
2005-07-26	Common Stock, $0.01 Par Value	S	11200	$0.85	Disposed	11930108	Indirect
2005-07-26	Common Stock, $0.01 Par Value	S	25660	$0.86	Disposed	11904448	Indirect
2005-07-26	Common Stock, $0.01 Par Value	S	2500	$0.87	Disposed	11901948	Indirect

Footnotes

F1: This amendment to the Form 4 originally filed on July 27, 2005 (the "Original Form 4") amends and restates the Original Form 4 in its entirety and is being filed solely to correct the amount of Targeted Genetics Corporation common stock beneficially owned by the reporting person. The Original Form 4 inadvertently overreported the reporting person's beneficial ownership of Targeted Genetics Corporation common stock by 25,000 shares.

F2: Shares are owned indirectly by Biogen Idec Inc. and directly by its wholly-owned subsidiary Biogen Idec MA Inc., fka Biogen, Inc.